Emerging discoveries in liquid biomarker research promise to transform the early detection, diagnosis and treatment ...
The U.S. Food and Drug Administration (FDA) has approved a new therapy regimen for patients with "double-positive" metastatic ...
A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit ...
Agenus’s metastatic colorectal cancer (mCRC) combination therapy has continued to show benefit after three years of treatment ...
UCSF researchers are using tiny "mini-organs" to model disease, personalize treatment, and understand human development. They ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results